Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract

Odense University Hospital

Status: Completed

Conditions: Gastric Cancer; Esophageal Cancer; Liver Cancer; Pancreatic Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT00511264

2007-10

Details and patient eligibility

About

Laparoscopic Ultrasound (LUS) is an important part of the pre-treatment evaluation of patients with upper gastrointestinal tract cancer (esophageal, gastric, pancreatic and liver cancer). When a suspect lesion is visualized during LUS a biopsy should be provided in order to differentiate between benign and malignant lesions. A new system for LUS guided biopsy has been developed, but how often these biopsies are clinically relevant (i.e. changing patient management)and how reliable are these biopsies are unknown.

The study hypothesis is that LUS guided biopsies are accurate and clinically relevant in the pre-treatment evaluation of patients with upper gastrointestinal tract cancer.

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Biopsy proven upper GI tract cancer
• Laparoscopic Ultrasound indicated during pre-treatment evaluation

Exclusion criteria

• Patients unfit for surgery